Evidence map›Paper›PMID 39911534›Full record

ArticlePlastic and reconstructive surgery. Global open2025

Platysma Prominence: Review and Expert Analysis of Clinical Presentation, Burden, and Treatment Considerations.

Ada Trindade de Almeida, Koenraad De Boulle, Z Paul Lorenc, Jean Carruthers, Andre Braz, Dario Bertossi, Elena Dimitrijevic, Sandhya Shimoga, René Hopfinger

Abstract read
In one paragraph

Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. [Cross-cultural adaptation and reliability validation of a Chinese version of the Clinician-reported Submental Fat Rating Scale].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2026
    Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ada Trindade de AlmeidaFrom Private Practice, São Paulo, Brazil.
Koenraad De BoulleAalst Dermatology Clinic, Aalst, Belgium.
Z Paul LorencPrivate Practice, New York, NY.
Jean CarruthersCarruthers Cosmetic, Vancouver, BC, Canada.
Andre BrazPrivate Practice, Rio De Janeiro, Brazil.
Dario BertossiHead and Neck Department, University of Verona, Verona, Italy.
Elena DimitrijevicAllergan Aesthetics, an AbbVie Company, Irvine, CA.
Sandhya ShimogaAllergan Aesthetics, an AbbVie Company, Irvine, CA.
René HopfingerAllergan Aesthetics, an AbbVie Company, Irvine, CA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Platysma prominence (PP) is a sign of aging in the lower face and neck characterized primarily by a blunting of the jawline and the presence of vertical banding along the anterior and posterior margins of the muscle on one or both sides of the neck. The aim of this review was to combine findings from the literature on topics relevant to PP with expert perspective to help guide clinical decision-making in assessment and treatment. Methods: A review of the literature focusing on platysma muscle anatomy and function; PP signs, characteristics, causes, clinical severity, and aesthetic and psychosocial effects; and treatment options for PP was performed and summarized. Expert clinical perspectives of these findings elucidated from the authors' experience were used to develop considerations for the evaluation and treatment of PP. Results: PP is an aesthetically undesirable condition that is bothersome to affected individuals and has negative effects on quality of life and psychological and emotional well-being. Knowledge of platysma muscle anatomy, proper patient assessment, and considerations in the use of onabotulinumtoxinA for the treatment of PP, including selection of the appropriate candidates and careful dosing and injection techniques, can produce consistent results with limited adverse events, potentially enhancing the patient's quality of life. Conclusions: PP is a bothersome condition with a detrimental impact on patient quality of life and psychological and emotional well-being. OnabotulinumtoxinA is a nonsurgical treatment option with a record of safe, consistent results in treating PP.

Identifiers

PMID39911534
PMCPMC11798379

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.